icd10coded.com
  • ICD-10 CM
    • ICD-10 CM Diagnosis Codes
    • Convert ICD-9 to ICD-10
    • Index of Diseases and Injuries
    • Index of External Cause of Injuries
    • Table of Neoplasms
    • Table of Drugs & Chemicals
    • POA Reporting Guidelines
    • POA Codes
    • Diagnosis Related Groups - MS-DRG
  • ICD-10 PCS
    • ICD-10 PCS Procedure Codes
    • ICD-10 PCS Index
    • ICD-10 PCS Definitions
    • Device Aggregation Table
    • Diagnosis Related Groups - MS-DRG
  • Coding Rules
    • Perinatal/Newborn diagnoses
    • Pediatric diagnoses
    • Maternity diagnoses
    • Adult diagnoses
    • Diagnoses for females only
    • Diagnoses for males only
    • Procedures for females only
    • Procedures for males only
    • Unacceptable principal diagnosis
    • Questionable admission codes
    • Manifestation code as principal diagnosis
  • Clinical Concept
    • Allergy
    • Cardiology
    • Endocrinology
    • Family Practice
    • Internal Medicine
    • OB/GYN
    • Orthopedics
    • Pediatrics
    • Physical Therapy
  • Search
  1. Home
  2. ICD-10 CM
  3. E70.331
  4. Feedback

ICD-10 Code E70.331
Hermansky-Pudlak syndrome

E70.331 is the medical classification code for oculocutaneous albinism type 1, a rare autosomal recessive genetic disorder characterized by a congenital deficiency or complete absence of melanin pigment in the skin, hair, and eyes. This condition is caused by pathogenic variants in the TYR gene, which provides instructions for producing the tyrosinase enzyme required for melanin biosynthesis. Clinically, affected individuals present with white or extremely light-colored hair, pale skin, and significant ocular abnormalities including nystagmus, reduced visual acuity, photophobia, strabismus, and foveal hypoplasia due to abnormal optic nerve routing. Because of the lack of photoprotective melanin, patients are exceptionally vulnerable to ultraviolet radiation damage, putting them at heightened risk for solar keratoses, severe sunburns, and cutaneous malignancies such as basal cell carcinoma, squamous cell carcinoma, and melanoma. Related conditions and classified variants within this spectrum include oculocutaneous albinism type 1A, oculocutaneous albinism type 1B, other forms of oculocutaneous albinism such as types 2 through 4, ocular albinism, and complex genetic syndromes featuring albinism like Hermansky-Pudlak syndrome and Chediak-Higashi syndrome.


E70.331 is a valid billable ICD-10 diagnosis code for Hermansky-Pudlak syndrome. It is found in the 2027 version of the ICD-10 CM Index and can be used in all HIPAA-covered transactions from Oct 01, 2026 - Sep 30, 2027.


The use of ICD-10 code E70.331 can also apply to:

  • Hermansky-Pudlak syndrome
MS-DRG - Medicare Severity-Diagnosis Related Group
  • MDC 10 Endocrine, Nutritional & Metabolic Diseases & Disorders
    Inborn Errors of Metabolism
    • DRG 642 - INBORN AND OTHER DISORDERS OF METABOLISM

Coding structure:

ICD-10 code E70.331 is based on the following Tabular structure:

Chapter 4: Endocrine, nutritional and metabolic diseases
  • Section E70-E88: Metabolic disorders
    • Category E70: Disorders of aromatic amino-acid metabolism

↑ Parent code:
E70.33 for Albinism with hematologic abnormality

E70.331_
Category
 
Etiology, Anatomic Site,
Severity, Other Vital Details
Extension

Should you use E70.331 or E70331 (with or without decimal point) when submitting claims?

DO NOT include the decimal point when electronically filing claims as it may be rejected. Some clearinghouses may remove it for you but to avoid having a rejected claim due to an invalid ICD-10 code, do not include the decimal point when submitting claims electronically.

Section E70-E88 — Metabolic disorders

Excludes1

  • androgen insensitivity syndrome (E34.5-)
  • congenital adrenal hyperplasia (E25.0)
  • hemolytic anemias attributable to enzyme disorders (D55.-)
  • Marfan syndrome (Q87.4-)
  • 5-alpha-reductase deficiency (E29.1)

Excludes2

  • Ehlers-Danlos syndromes (Q79.6-)
  1. E70 Disorders of aromatic amino-acid metabolism

    1. E70.0 Classical phenylketonuria

    2. E70.1 Other hyperphenylalaninemias

    3. E70.2 Disorders of tyrosine metabolism

      1. E70.20 Disorder of tyrosine metabolism, unspecified

      2. E70.21 Tyrosinemia

        Inclusion term(s):

        • Hypertyrosinemia
      3. E70.29 Other disorders of tyrosine metabolism

        Inclusion term(s):

        • Alkaptonuria
        • Ochronosis
    4. E70.3 Albinism

      1. E70.30 Albinism, unspecified

      2. E70.31 Ocular albinism

        • E70.310 X-linked ocular albinism
        • E70.311 Autosomal recessive ocular albinism
        • E70.318 Other ocular albinism
        • E70.319 Ocular albinism, unspecified
      3. E70.32 Oculocutaneous albinism

        • E70.320 Tyrosinase negative oculocutaneous albinism

          Inclusion term(s):

          • Albinism I
          • Oculocutaneous albinism ty-neg
        • E70.321 Tyrosinase positive oculocutaneous albinism

          Inclusion term(s):

          • Albinism II
          • Oculocutaneous albinism ty-pos
        • E70.328 Other oculocutaneous albinism

          Inclusion term(s):

          • Cross syndrome
        • E70.329 Oculocutaneous albinism, unspecified
      4. E70.33 Albinism with hematologic abnormality

        • E70.330 Chediak-Higashi syndrome
        • E70.331 Hermansky-Pudlak syndrome
        • E70.338 Other albinism with hematologic abnormality
        • E70.339 Albinism with hematologic abnormality, unspecified
      5. E70.39 Other specified albinism

        Inclusion term(s):

        • Piebaldism
    5. E70.4 Disorders of histidine metabolism

      1. E70.40 Disorders of histidine metabolism, unspecified

      2. E70.41 Histidinemia

      3. E70.49 Other disorders of histidine metabolism

    6. E70.5 Disorders of tryptophan metabolism

    7. E70.8 Other disorders of aromatic amino-acid metabolism

      1. E70.81 Aromatic L-amino acid decarboxylase deficiency

        Inclusion term(s):

        • AADC deficiency
      2. E70.89 Other disorders of aromatic amino-acid metabolism

    8. E70.9 Disorder of aromatic amino-acid metabolism, unspecified

Abbreviations used here:

NEC Not elsewhere classifiable
This abbreviation in the Tabular List represents “other specified”. When a specific code is not available for a condition, the Tabular List includes an NEC entry under a code to identify the code as the “other specified” code.

NOS Not otherwise specified
This abbreviation is the equivalent of unspecified.

This note further define, or give examples of, the content of the code or category.

List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of “other specified” codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.

Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.

A type 1 Excludes note is a pure excludes. It means 'NOT CODED HERE!' An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.

A type 2 Excludes note represents 'Not included here'. An Excludes2 note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When an Excludes2 note appears under a code it is acceptable to use both the code and the excluded code together.

A “code also” note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction. The sequencing depends on the circumstances of the encounter.

Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.

Feedback

Finding the right ICD-10 code is not always easy. Submitting the wrong code can cause delays in processing claims and payments. Please let us know if there is anything we can do better to help make your job easier. We strive to be the best ICD-10 site possible.

Share this page

Was the information found on this page useful? Share this page with a friend or colleague. They may also find it useful. We can send an email to someone you designate with this information as well.

  • ICD-10 CM
  • ICD-10 PCS
  • FAQs
  • Sitemap
  • →
  • Terms of Use
  • Privacy Policy
  • Contact Us
Follow @icd10coded

ICD-10 data provided by CMS (Centers for Medicare & Medicaid Services). All content is provided “AS IS”. The latest version of ICD-10 is updated each year on October 1.

1.261103a — Privacy Settings